$17.26
2.43% today
Nasdaq, Feb 28, 05:18 pm CET
ISIN
US8523123052
Symbol
STAA

STAAR Surgical Company Stock price

$17.69
-6.90 28.06% 1M
-14.68 45.35% 6M
-6.60 27.17% YTD
-14.99 45.87% 1Y
-61.63 77.70% 3Y
-13.34 42.99% 5Y
+10.83 157.87% 10Y
Nasdaq, Closing price Thu, Feb 27 2025
+0.60 3.51%
ISIN
US8523123052
Symbol
STAA
Sector

Key metrics

Market capitalization $872.57m
Enterprise Value $680.82m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 2.17
P/S ratio (TTM) P/S ratio 2.78
P/B ratio (TTM) P/B ratio 2.19
Revenue growth (TTM) Revenue growth -2.64%
Revenue (TTM) Revenue $313.90m
EBIT (operating result TTM) EBIT $-12.61m
Free Cash Flow (TTM) Free Cash Flow $-7.67m
Cash position $230.49m
EPS (TTM) EPS $-0.41
P/E forward negative
P/S forward 3.35
EV/Sales forward 2.61
Short interest 15.95%
Show more

Is STAAR Surgical Company a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,809 stocks worldwide.

STAAR Surgical Company Stock Analysis

Unlock Scores for Free

Analyst Opinions

13 Analysts have issued a STAAR Surgical Company forecast:

3x Buy
23%
9x Hold
69%
1x Sell
8%

Analyst Opinions

13 Analysts have issued a STAAR Surgical Company forecast:

Buy
23%
Hold
69%
Sell
8%

Financial data from STAAR Surgical Company

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
314 314
3% 3%
100%
- Direct Costs 74 74
7% 7%
24%
240 240
5% 5%
76%
- Selling and Administrative Expenses 191 191
9% 9%
61%
- Research and Development Expense 54 54
22% 22%
17%
-5.72 -5.72
117% 117%
-2%
- Depreciation and Amortization 6.89 6.89
28% 28%
2%
EBIT (Operating Income) EBIT -13 -13
145% 145%
-4%
Net Profit -20 -20
195% 195%
-6%

In millions USD.

Don't miss a Thing! We will send you all news about STAAR Surgical Company directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

STAAR Surgical Company Stock News

Neutral
Business Wire
2 days ago
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced a leadership transition. Stephen C. Farrell, current Lead Independent Director of the STAAR Board of Directors, has been appointed President and CEO, effective February 26, 2025. Tom Fr...
Neutral
Seeking Alpha
15 days ago
STAAR Surgical Company (NASDAQ:STAA ) Q4 2024 Earnings Call Transcript February 11, 2025 5:00 PM ET Company Participants Brian Moore - VP, Investor Relations and Corporate Development Tom Frinzi - Chair of the Board, President and CEO Patrick Williams - CFO Conference Call Participants Iseult Mcmahon - BTIG Tom Stephan - Stifel Anthony Petrone - Mizuho Macauley Kilbane - William Blair Patrick W...
Positive
Seeking Alpha
16 days ago
STAAR Surgical's Q4 results were severely impacted by lower demand and high inventory levels in China. Global growth ex-China was 17% in Q4 and is expected to remain strong at 12% for FY25, with US growth of close to 15%. Cash burn is expected to be significant, but the company is financially healthy, having $232 million in cash and no debt on its balance sheet.
More STAAR Surgical Company News

Company Profile

STAAR Surgical Co. engages in the development, manufacture, production, marketing, and sale of implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. It specializes in refractive and cataract solutions. Its products include intraocular lens and implantable collamer lens. The company was founded in 1982 and is headquartered in Lake Forest, CA.

Head office United States
CEO Stephen Farrell
Employees 1,211
Founded 1982
Website www.staar.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today